Clinical Observation of Employment of Umbilical Cord Derived Mesenchymal Stem Cell for Juvenile Idiopathic Arthritis Therapy

Stem Cells International
Liming WangMingyuan Wu

Abstract

Juvenile idiopathic arthritis (JIA), known as Juvenile rheumatoid arthritis, is the most common type of arthritis in children aged under 17. It may cause sequelae due to lack of effective treatment. The goal of this study is to explore the therapeutic effect of umbilical cord mesenchymal stem cells (UC-MSCs) for JIA. Ten JIA patients were treated with UC-MSCs and received second infusion three months later. Some key values such as 28-joint disease activity score (DAS28), TNF-α, IL-6, and regulatory T cells (Tregs) were evaluated. Data were collected at 3 months and 6 months after first treatment. DAS28 score of 10 patients was between 2.6 and 3.2 at three months after infusion. WBC, ESR, and CRP were significantly decreased while Tregs were remarkably increased and IL-6 and TNF-α were declined. Similar changes of above values were found after 6 months. At the same time, the amount of NSAIDS and steroid usage in patients was reduced. However, no significant changes were found comparing the data from 3 and 6 months. These results suggest that UC-MSCs can reduce inflammatory cytokines, improve immune network effects, adjust immune tolerance, and effectively alleviate the symptoms and they might provide a safe and novel approach fo...Continue Reading

References

Oct 6, 2005·JAMA : the Journal of the American Medical Association·Philip J Hashkes, Ronald M Laxer
Oct 6, 2005·JAMA : the Journal of the American Medical Association·Sarah RingoldRichard M Glass
Aug 1, 2007·Blood·Alma J Nauta, Willem E Fibbe
Dec 8, 2009·Stem Cells·Husein K Salem, Chris Thiemermann
Jul 12, 2011·Stem Cells and Development·Nina ZippelEdda Tobiasch
Apr 14, 2012·TheScientificWorldJournal·Yu ZhangEdda Tobiasch
Jun 29, 2013·Methods in Molecular Biology·Rony Atoui, Ray C J Chiu
Apr 17, 2014·Stem Cells International·Weian ZhaoMauro Krampera
Feb 20, 2015·Cell Transplantation·Andrea Del FattoreMaurizio Muraca
Mar 24, 2015·Bioscience Reports·Imran UllahGyu Jin Rho
Mar 31, 2015·Stem Cells International·Katherine Athayde Teixeira de CarvalhoJuan Carlos Chachques
Apr 7, 2015·Expert Review of Clinical Immunology·Andreas WoernerMichaël Hofer
Apr 15, 2015·Microbiology and Immunology·Shereen ShawkiRabab El Hawary

❮ Previous
Next ❯

Citations

May 22, 2016·Clinical Reviews in Allergy & Immunology·Alexandre T J MariaPhilippe Guilpain
Oct 14, 2017·Archivum Immunologiae Et Therapiae Experimentalis·Krzysztof Orczyk, Elzbieta Smolewska
Jul 12, 2017·F1000Research·Susan Canny, Elizabeth Mellins
Jun 12, 2021·Pediatric Rheumatology Online Journal·Stephen C WongDeborah K McCurdy

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
flow cytometry
FACS

Software Mentioned

SPSS
Excel

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

© 2022 Meta ULC. All rights reserved